drugset / Trial / NCT00426946
Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the present study is to prospectively assess the anti-depressant effectiveness of reboxetine in children and adolescents, as compared with fluoxetine, in a randomized controlled open-label trial.
Timeline
- Start
- 2005-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reboxetine | Unknown | 4 mg | — |
| Subject | Reboxetine | Unknown | 8 mg | — |